author-photo

Amie Blanco

University of California, San Francisco

58

Papers

1685

Citations

Citation Trend

Filter By

Papers (41) Sort By

Journal Conference Others

The marginal diagnostic benefit of pancreatic cancer molecular profiling after germline testing.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Implementation of an Embedded In-Clinic Genetic Testing Station to Optimize Germline Testing for Patients with Pancreatic Adenocarcinoma.

2021 Oncologist
Show All
- Source
- Cite
- Save
Citations (0)
S305 Improving Identification of Patients Meeting Lynch Syndrome Testing Criteria in Endoscopy

2021 The American Journal of Gastroenterology
Show All
- Source
- Cite
- Save
Citations (0)
The WISDOM study: a new approach to screening can and should be tested.

2021 Breast Cancer Research and Treatment
Show All
- Source
- Cite
- Save
Citations (0)
Streamlining the genetics pipeline to increase testing for patients at risk for hereditary prostate cancer.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

2020 Nature Genetics
Show All
- Source
- Cite
- Save
Citations (56)
Abstract OT3-03-02: Personalized breast cancer screening in a population-based study: Women informed to screen depending on measures of risk (WISDOM)

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants.

2020 Genetics in Medicine
Show All
- Source
- Cite
- Save
Citations (34)
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer.

2019
Show All
- Source
- Cite
- Save
Citations (15)
BRCA1 and BRCA2 Pathogenic Sequence Variants in Women of African Origin or Ancestry

2019 Human Mutation
Show All
- Source
- Cite
- Save
Citations (7)